Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 26, 2023

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2028

Conditions
Small-cell Lung Cancer
Interventions
RADIATION

split-course adaptive hypofractionated radiotherapy

Each treatment cycle comprises a solitary radiotherapy session, which allows for its integration with chemotherapy and immunotherapy. The radiotherapy sessions are scheduled at three-week intervals, thereby affording extended recovery periods for normal tissues. An adaptive radiotherapy plan is implemented for each cycle, enabling precise adjustments to the treatment target area in response to the reduction in tumor volume.

Trial Locations (1)

350000

Fujian Medical University Union Hospital,, Fuzhou

All Listed Sponsors
lead

Fujian Medical University Union Hospital

OTHER